0001477932-21-003647.txt : 20210527
0001477932-21-003647.hdr.sgml : 20210527
20210527193528
ACCESSION NUMBER: 0001477932-21-003647
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20201023
FILED AS OF DATE: 20210527
DATE AS OF CHANGE: 20210527
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Berlent Jonathan
CENTRAL INDEX KEY: 0001319880
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-55908
FILM NUMBER: 21975187
MAIL ADDRESS:
STREET 1: 1620 BEACON PLACE
CITY: OXNARD
STATE: CA
ZIP: 93033
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Cure Pharmaceutical Holding Corp.
CENTRAL INDEX KEY: 0001643301
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 371765151
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1620 BEACON PLACE
CITY: OXNARD
STATE: CA
ZIP: 93033
BUSINESS PHONE: 805-824-0410
MAIL ADDRESS:
STREET 1: 1620 BEACON PLACE
CITY: OXNARD
STATE: CA
ZIP: 93033
FORMER COMPANY:
FORMER CONFORMED NAME: Makkanotti Group Corp.
DATE OF NAME CHANGE: 20150526
4
1
form4.xml
FORM 4
X0306
4
2020-10-23-05:00
false
0001643301
Cure Pharmaceutical Holding Corp.
CURR
0001319880
Berlent Jonathan
1620 BEACON PLACE
OXNARD
CA
93033
false
true
false
false
Chief Business Officer
Stock Option
1.20
2020-10-23-05:00
4
A
false
62500
0.00
A
2020-10-23-05:00
2030-10-23-05:00
Common Stock
62500
62500
D
Stock Option
1.20
2020-10-23-05:00
4
A
false
187500
0.00
A
2030-10-23-05:00
Common Stock
187500
187500
D
The option becomes exercisable on the basis determined by the equity incentive plan with 14.28% of the option vesting on the first quarter anniversary of vesting start date. For each additional quarter of the participant's service the option will continue to vest until the vested ratio is 100%. This late filing is due to an inadvertent administrative error and not any error of the reporting person.
/s/ Jonathan Berlent
2021-05-27-05:00